Emily Isaacs
Rheumatology · Fort Worth, TXNPI 1114927779
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $148,363 of the $158,147 with a category attached, or 93.8%. AbbVie accounts for 64.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $55,800 and has fallen 72.1% since, to $15,547 in 2023. Among rheumatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $779.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$101K
- Amgen$42K
- Bristol Myers Squibb$13K
- Pfizer$2K
- AstraZeneca$47
- Novartis$36
- plus $99 from 5 others
What the payments were for
- Consulting fees$6080%
- Speaking & faculty fees$148,36394%
- Travel & lodging$5,6664%
- Food & beverage$3,4952%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 120 | $101,262 |
| Amgen(2 entities) | 49 | $41,608 |
| Bristol Myers Squibb | 16 | $12,702 |
| Pfizer | 6 | $2,393 |
| AstraZeneca | 3 | $47 |
| Novartis | 2 | $36 |
| GSK | 2 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Seagen Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
| Johnson & Johnson | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$158,147 in reported general payments places this provider in the 95th percentile of 512 rheumatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 15 | $1,266 |
| Hydroxychloroquine Sulfate | 22 | $943 |
| MethotrexateMethotrexate Sodium | 26 | $490 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 20 | $189 |
| Prednisone | 14 | $100 |
| Diclofenac Sodium | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Fort Worth
- Himabindu ReddyFort Worth$43K
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
- Frank WellborneNew Braunfels$1.4M
- Christopher ParkerWest Lake Hills$1.4M
- Pendleton WickershamSan Antonio$954K
- Henry TownsendPlano$738K
- Zoran KurepaDallas$483K
- Giovanni GeslaniDallas$415K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.